Diabetes groups call for better regulation of insulin pumpsBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1476 (Published 17 March 2015) Cite this as: BMJ 2015;350:h1476
- Susan Mayor
Regulatory agencies should adopt a more rigorous, standardised approach to assessing the safety of insulin pumps and require manufacturers to provide safety data during development and throughout clinical use, suggest leading diabetes organisations in new recommendations to reduce adverse events and deaths among patients undergoing insulin pump therapy.
A working group of the European Association for the Study of Diabetes and the American Diabetes Association warns in a statement in Diabetologia that insulin pump users are “exposed to significant and potentially fatal hazards.”1 Potential problems include pump failure, blockage of the insulin infusion set, and problems …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial